6-((3S,4S)-4-Methyl-1-pyrimidin-2-ylmethyl-pyrrolidin-3-yl-1-(tetrahydro-pyran-4-yl)-1,5-dihydro-pryazolo[3,4-d]pyrimidin-4-one | |
---|---|
Trade Name | |
Orphan Indication | Sickle cell anemia |
USA Market Approval | USA |
USA Designation Date | 2014-09-04 00:00:00 |
Sponsor | Pfizer, Inc.;500 Arcola Road;Collegeville, Pennsylvania, 19426 |
Related Access Program